Cargando…

Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage

Detalles Bibliográficos
Autores principales: Liu, Lei, Yue, Peng, Zhang, Yue, Hua, Yimin, Bi, Wenwei, Yan, Hualin, Liao, Hongyu, Li, Jiawen, Zhou, Kaiyu, Li, Yifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724271/
https://www.ncbi.nlm.nih.gov/pubmed/34980885
http://dx.doi.org/10.1038/s41392-021-00715-z
_version_ 1784625890924167168
author Liu, Lei
Yue, Peng
Zhang, Yue
Hua, Yimin
Bi, Wenwei
Yan, Hualin
Liao, Hongyu
Li, Jiawen
Zhou, Kaiyu
Li, Yifei
author_facet Liu, Lei
Yue, Peng
Zhang, Yue
Hua, Yimin
Bi, Wenwei
Yan, Hualin
Liao, Hongyu
Li, Jiawen
Zhou, Kaiyu
Li, Yifei
author_sort Liu, Lei
collection PubMed
description
format Online
Article
Text
id pubmed-8724271
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87242712022-01-18 Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage Liu, Lei Yue, Peng Zhang, Yue Hua, Yimin Bi, Wenwei Yan, Hualin Liao, Hongyu Li, Jiawen Zhou, Kaiyu Li, Yifei Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-01-03 /pmc/articles/PMC8724271/ /pubmed/34980885 http://dx.doi.org/10.1038/s41392-021-00715-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Liu, Lei
Yue, Peng
Zhang, Yue
Hua, Yimin
Bi, Wenwei
Yan, Hualin
Liao, Hongyu
Li, Jiawen
Zhou, Kaiyu
Li, Yifei
Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage
title Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage
title_full Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage
title_fullStr Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage
title_full_unstemmed Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage
title_short Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage
title_sort non-cell-autonomous manner of aav administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ecm to reduce viral dosage
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724271/
https://www.ncbi.nlm.nih.gov/pubmed/34980885
http://dx.doi.org/10.1038/s41392-021-00715-z
work_keys_str_mv AT liulei noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT yuepeng noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT zhangyue noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT huayimin noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT biwenwei noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT yanhualin noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT liaohongyu noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT lijiawen noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT zhoukaiyu noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage
AT liyifei noncellautonomousmannerofaavadministrationtoattenuatecardiomyocytehypertrophybytargetingparacrinesignalingonecmtoreduceviraldosage